Cited by 137Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsCerebrospinal fluid and hydrocephalus

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4)

Open access

Gauthier, Serge, Patterson, Christopher, Chertkow, Howard, Gordon, Michael, Herrmann, Nathan, Rockwood, Kenneth, Rosa-Neto, Pedro, Soucy, Jean-Paul·2012·Canadian Geriatrics Journal

DOI 10.5770/cgj.15.49PMC PMC3516356

Open this paper in CoChat — free account Open PDF

Abstract

The 4th CCCDTD convened in May 2012 in Montreal with the primary aim of updating the previous diagnostic approach to AD, taking into account the revised diagnostic criteria proposed by the International Working Group (IWG) and the recommendations made by the National Institute on Aging-Alzheimer Association workgroups.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.5770/cgj.15.49

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411
Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease
Albert, M., DeKosky, S. T., Dickson, D. W., Dubois, B., Feldman, H., Fox, N. C., Gamst, A. C., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.1.96 · Cited by 2,643
Revising the definition of Alzheimer's disease: a new lexicon
Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869
Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project
(2003) · Quality and Safety in Health Care · doi:10.1136/qhc.12.1.18 · Cited by 1,446
Diagnosis and treatment of dementia: 2. Diagnosis
Feldman, H., Jacova, C., Robillard, A., Garcia, A. A., Chow, T. W., BORRIE, M. J., Schipper, H. M., Blair, M., Kertesz, A., & Chertkow, H. M. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.070798 · Cited by 358

Flagged first, then by citations

Show all 21 references

Sorted by citations

Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
The Alzheimer’s Disease Clinical Spectrum
Atri, A. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.10.009 · Cited by 623
“treatments for AD dementia and are recommended broadly in consensus guidelines and practice parameters.(1,52,61,62) ChEIs and memantine also have complementary mechanisms of action, potentially additive effects, and demonstrate acceptable tolerability and safety profiles.”
Current and future treatments in Alzheimer’s disease
Atri, A. (2019) · Seminars in Neurology · doi:10.1055/s-0039-1678581 · Cited by 309
Alzheimer Disease
Apostolova, L. G. (2016) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000307 · Cited by 277
Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia
Ismail, Z., Black, S. E., Camicioli, R., Chertkow, H., Herrmann, N., Laforce, R., Montero‐Odasso, M., Rockwood, K., Rosa‐Neto, P., Seitz, D., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12105 · Cited by 245
Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration
Rivard, L., Friberg, L., Conen, D., Healey, J. S., Berge, T., Boriani, G., Brandes, A., Calkins, H., Camm, A. J., Chen, L. Y., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.055018 · Cited by 214
A Meta-Analysis of the Efficacy of Donepezil, Rivastigmine, Galantamine, and Memantine in Relation to Severity of Alzheimer's Disease
Santo, S. G. D., Prinelli, F., Adorni, F., Caltagirone, C., & Musicco, M. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122140 · Cited by 186
A review of clinical treatment considerations of donepezil in severe Alzheimer's disease
Adlimoghaddam, A., Neuendorff, M., Roy, B., & Albensi, B. C. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13035 · Cited by 154
Systematic review of recent dementia practice guidelines
Ngo, J., & Holroyd-Leduc, J. M. (2014) · Age and Ageing · doi:10.1093/ageing/afu143 · Cited by 132
Antipsychotic Use in Dementia: Is There a Problem and Are There Solutions?
Kirkham, J., Sherman, C., Velkers, C., Maxwell, C., Gill, S., Rochon, P., & Seitz, D. (2017) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716673321 · Cited by 113
Diagnosis and management of Alzheimer's disease: Past, present and future ethical issues
Gauthier, S. G., Leuzy, A., Racine, É., & Rosa‐Neto, P. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.01.003 · Cited by 119
Present Algorithms and Future Treatments for Alzheimer’s Disease
Grossberg, G. T., Tong, G., Burke, A. D., & Tariot, P. N. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180903 · Cited by 111
Early-onset dementias: diagnostic and etiological considerations
Masellis, M., Sherborn, K., Rosa‐Neto, P., Sadovnick, A. D., Hsiung, G. R., Black, S. E., Prasad, S., Williams, M., & Gauthier, S. G. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt197 · Cited by 102
Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia: recommendations for family physicians.
Moore, A. E., Patterson, C., Lee, L. S., Vedel, I., & Bergman, H. (2014) · Europe PMC (PubMed Central) · Cited by 93
Long-Term Efficacy and Toxicity of Cholinesterase Inhibitors in the Treatment of Alzheimer Disease
Hogan, D. B. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405901202 · Cited by 93
Depression in Alzheimer's Disease: A Delphi Consensus on Etiology, Risk Factors, and Clinical Management
Agüera-Ortíz, L., García-Ramos, R., Pérez, F. J. G., López‐Álvarez, J., Rodríguez, J. M. M., Rodríguez, F. J. O., Pueyo, J. O., Valero, C. P., & Porta-Etessam, J. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.638651 · Cited by 84
Therapeutic Strategies and Drug Development for Vascular Cognitive Impairment
Smith, E. E., Cieślak, A., Barber, P. A., Chen, J. Y., Chen, Y., Donnini, I., Edwards, J. D., Frayne, R., Field, T. S., Hegedus, J., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005568 · Cited by 61
Guidelines for dementia or Parkinson’s disease with depression or anxiety: a systematic review
Goodarzi, Z., Mele, B., Guo, S., Hanson, H. M., Jetté, N., Patten, S. B., Pringsheim, T. M., & Holroyd-Leduc, J. M. (2016) · BMC Neurology · doi:10.1186/s12883-016-0754-5 · Cited by 57
Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers
Bensaïdane, M. R., Beauregard, J., Poulin, S. P., Buteau, F.-A., Guimond, J. V., Bergeron, D., Verret, L., Fortin, M., Houde, M., Bouchard, R. W., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151180 · Cited by 50
Assessing Palliative Care Content in Dementia Care Guidelines: A Systematic Review
Durepos, P., Wickson‐Griffiths, A., Hazzan, A. A., Kaasalainen, S., Vastis, V., Battistella, L., & Παπαϊωάννου, Α. (2017) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2016.10.368 · Cited by 45
Is there a preference for PET or SPECT brain imaging in diagnosing dementia? The views of people with dementia, carers, and healthy controls
Bamford, C. H., Olsen, K., Davison, C., Barnett, N. A., Lloyd, J. J., Williams, D. M., Firbank, M., Mason, H., Donaldson, C., & O'Brien, J. T. (2015) · International Psychogeriatrics · doi:10.1017/s1041610215001039 · Cited by 42
Canadian Consensus Conference on Diagnosis and Treatment of Dementia (CCCDTD)5: Guidelines for management of vascular cognitive impairment
Smith, E. E., Barber, P. A., Field, T. S., Ganesh, A., Hachinski, V., Hogan, D. B., Lanctôt, K. L., Lindsay, M. P., Sharma, M., Swartz, R. H., et al. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12056 · Cited by 41
Anti-dementia medications: current prescriptions in clinical practice and new agents in progress
Stella, F., Radanovic, M., Canineu, P. R., de Paula, V. D. J. R., & Forlenza, O. V. (2015) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098615592116 · Cited by 39
Addressing ethical challenges of disclosure in dementia prediction: limitations of current guidelines and suggestions to proceed
Alpinar-Şencan, Z., & Schicktanz, S. (2020) · BMC Medical Ethics · doi:10.1186/s12910-020-00476-4 · Cited by 39
Alzheimer’s Biomarkers From Multiple Modalities Selectively Discriminate Clinical Status: Relative Importance of Salivary Metabolomics Panels, Genetic, Lifestyle, Cognitive, Functional Health and Demographic Risk Markers
Sapkota, S., Huan, T., Tran, T., Zheng, J., Camicioli, R. M., Li, L., & Dixon, R. A. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00296 · Cited by 36
Vascular Cognitive Impairment
Smith, E. E. (2016) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000304 · Cited by 35
Antipsychotics and dementia in Canada: a retrospective cross-sectional study of four health sectors
Rios, S., Perlman, C. M., Costa, A. P., Heckman, G. A., Hirdes, J. P., & Mitchell, L. A. (2017) · BMC Geriatrics · doi:10.1186/s12877-017-0636-8 · Cited by 31
The “Rising Tide” of dementia in Canada
Chang, F., Patel, T., & Schulz, M. E. (2015) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/1715163515588107 · Cited by 30
CCCDTD5 recommendations on early and timely assessment of neurocognitive disorders using cognitive, behavioral, and functional scales
Tang‐Wai, D. F., Smith, E. E., Bruneau, M., Burhan, A. M., Chatterjee, A., Chertkow, H. M., Choudhury, S., Dorri, E., Ducharme, S., Fischer, C. E., et al. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12057 · Cited by 30
Neurocognition in Adult Congenital Heart Disease: How to Monitor and Prevent Progressive Decline
Keir, M., Ebert, P. L., Kovacs, A. H., Smith, J., Kwan, E., Field, T. S., Brossard‐Racine, M., & Marelli, A. J. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.06.020 · Cited by 28
The Behavioral/Dysexecutive Variant of Alzheimer’s Disease: A Case Series with Clinical, Neuropsychological, and FDG-PET Characterization
Bergeron, D., Sellami, L., Poulin, S. P., Verret, L., Bouchard, R. W., & Laforce, R. J. (2020) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000511210 · Cited by 28
Assessing the Preparedness of the Canadian Health Care System Infrastructure for an Alzheimer's Treatment
Liu, J., Hlávka, J. P., Coulter, D., Baxi, S. M., Mattke, S., & Gidengil, C. A. (2019) · RAND Corporation eBooks · doi:10.7249/rr2744 · Cited by 28
A 2-Year Prospective Cohort Study of Antidementia Drug Non-Persistency in Mild-to-Moderate Alzheimer's Disease in Europe
The ICTUS Group, Gardette, V., Lapeyre‐Mestre, M., Piau, A., Gallini, A., Cantet, C., Montastruc, J., Vellas, B. J., & Andrieu, S. (2014) · CNS Drugs · doi:10.1007/s40263-013-0133-3 · Cited by 28
Cognitive Change in Donepezil Treated Patients with Vascular or Mixed Dementia
Rockwood, K. J., Mitnitski, A., Black, S. E., Richard, M., & Defoy, I. (2013) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100014670 · Cited by 27
Informing Understandings of Mild Cognitive Impairment for Older Adults: Implications From a Scoping Review
Fang, M. L., Coatta, K., Badger, M., Wu, S., Easton, M., Nygård, L., Astell, A. J., & Sixsmith, A. J. (2015) · Journal of Applied Gerontology · doi:10.1177/0733464815589987 · Cited by 31
Tolerability of Cholinesterase Inhibitors: A Population-Based Study of Persistence, Adherence, and Switching
Fisher, A., Carney, G., Bassett, K. L., & Dormuth, C. R. (2017) · Drugs & Aging · doi:10.1007/s40266-017-0438-x · Cited by 25
Kynurenines and other novel therapeutic strategies in the treatment of dementia
Majláth, Z., Tajti, J., & Vécsei, L. (2013) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285613494989 · Cited by 23
Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians
Rosa‐Neto, P., Hsiung, G. R., Masellis, M., & participants, O. B. O. T. C. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt223 · Cited by 24
Deconstructing Chronic Low Back Pain in the Older Adult–Step by Step Evidence and Expert-Based Recommendations for Evaluation and Treatment: Part XI: Dementia
Wright, R. M., Malec, M., Shega, J. W., Rodríguez, E., Kulas, J. F., Morrow, L. A., Rodakowski, J. L., Semla, T. P., & Weiner, D. K. (2016) · Pain Medicine · doi:10.1093/pm/pnw247 · Cited by 22
Validation and diagnostic accuracy of predictive curves for age-associated longitudinal cognitive decline in older adults
Bernier, P. J., Gourdeau, C., Carmichael, P., Beauchemin, J., Verreault, R., Bouchard, R. W., Kröger, E., & Laforce, R. J. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.160792 · Cited by 21
Impact of the Quebec Alzheimer Plan on the detection and management of Alzheimer disease and other neurocognitive disorders in primary health care: a retrospective study
Vedel, I., Sourial, N., Arsenault‐Lapierre, G., Godard‐Sebillotte, C., & Bergman, H. (2019) · CMAJ Open · doi:10.9778/cmajo.20190053 · Cited by 20
Optimizing Prescribing of Antipsychotics in Long-Term Care (OPAL): A Stepped-Wedge Trial
Kirkham, J. G., Maxwell, C. J., Velkers, C., Leung, R. H., Moffat, K., & Seitz, D. P. (2019) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.07.025 · Cited by 17
Managing neuropsychiatric symptoms in patients with dementia
Watt, J. A., Thompson, W., Marple, R., Brown, D., & Liu, B. (2022) · BMJ · doi:10.1136/bmj-2021-069187 · Cited by 18
Improving dementia care: insights from audit and feedback in interdisciplinary primary care sites
Arsenault‐Lapierre, G., Berre, M. L., Rojas‐Rozo, L., McAiney, C. A., Ingram, J., Lee, L. S., & Vedel, I. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-07672-5 · Cited by 18
The New Criteria for Alzheimer’s Disease - Implications for Geriatricians*
Molin, P., & Rockwood, K. J. (2016) · Canadian Geriatrics Journal · doi:10.5770/cgj.19.207 · Cited by 22
Downstream consequences of abnormal cognitive screening in older adults seen pretreatment in a geriatric oncology clinic
Malik, U., Alam, Z., Loucks, A., Jin, R., Yokom, D. W., Watt, S., Berger, A. S., Romanovsky, L., Puts, M. T. E., & Alibhai, S. M. H. (2019) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2019.10.022 · Cited by 16
Le Plan Alzheimer québécois, un plan basé sur les soins primaires
Arsenault‐Lapierre, G., Godard‐Sebillotte, C., Sourial, N., Couturier, Y., Bouchard, P., Rojas‐Rozo, L., Pilon, C., Bergman, H., & Vedel, I. (2020) · Santé Publique · doi:10.3917/spub.204.0375 · Cited by 16
Psychotropic and Cognitive-Enhancing Medication Use and Its Documentation in Contemporary Long-term Care Practice
Rojas‐Fernandez, C. H., Mikhail, M., & Brown, S. G. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028013520196 · Cited by 16
Structured approach to patients with memory difficulties in family practice.
Lee, L. S., Weston, W. W., Heckman, G. A., Gagnon, M., Lee, F. J., & Sloka, S. (2013) · Europe PMC (PubMed Central) · Cited by 14
Intraindividual variability measured with dispersion across diagnostic groups in a memory clinic sample
Grewal, K. S., O’Connell, M. E., Kirk, A., MacDonald, S. W. S., & Morgan, D. (2021) · Applied Neuropsychology Adult · doi:10.1080/23279095.2021.1970552 · Cited by 15
Exploring Rural Family Physicians’ Challenges in Providing Dementia Care: A Qualitative Study
Constantinescu, A., Li, H., Yu, J. W., Hoggard, C., & Holroyd-Leduc, J. M. (2018) · Canadian Journal on Aging / La Revue canadienne du vieillissement · doi:10.1017/s0714980818000417 · Cited by 15
Disease-modifying drugs for Alzheimer disease: implications for people in Canada
Watt, J. A., Isaranuwatchai, W., Grossman, L., & Straus, S. E. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.230595 · Cited by 14
CCCDTD5: Reducing the risk of later‐life dementia. Evidence informing the Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD‐5)
Rockwood, K. J., Andrew, M. K., Aubertin‐Leheudre, M., Belleville, S., Bherer, L., Bowles, S. K., Kehler, D. S., Lim, A. S. P., Middleton, L. E., Phillips, N. A., et al. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12083 · Cited by 17
The Cultural Diversity of Dementia Patients and Caregivers in Primary Care Case Management: a Pilot Mixed Methods Study
Yang, X. Q., Vedel, I., & Khanassov, V. (2021) · Canadian Geriatrics Journal · doi:10.5770/cgj.24.490 · Cited by 14
Primary care clinicians’ knowledge, attitudes, and practices concerning dementia
Arsenault‐Lapierre, G., Henein, M., Rojas‐Rozo, L., Sourial, N., Bergman, H., Couturier, Y., & Vedel, I. (2021) · Canadian Family Physician · doi:10.46747/cfp.6710731 · Cited by 14
Clinical Complexity and Use of Antipsychotics and Restraints in Long-Term Care Residents with Parkinson’s Disease
Heckman, G. A., Crizzle, A. M., Chen, J., Pringsheim, T. M., Jetté, N., Kergoat, M., Eckel, L., & Hirdes, J. P. (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-160931 · Cited by 14
Risks and benefits of current and novel drugs to treat agitation in Alzheimer’s disease
Herrmann, N., Wang, H. J., Song, B. X., Bawa, K. K., & Lanctôt, K. L. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2136162 · Cited by 14
The Depistage Cognitif de Quebec: a new clinician’s tool for early recognition of atypical dementia
Sellami, L., Meilleur-Durand, S., Chouinard, A.-M., Bergeron, D., Verret, L., Poulin, S., Jean, L., Fortin, M.-P., Nadeau, Y., Molin, P., et al. (2018) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000494348 · Cited by 14
Consensus Statement Regarding the Application of Biogen to Health Canada for Approval of Aducanumab
Chertkow, H. M., Rockwood, K. J., Hogan, D. B., Phillips, N. D., Montero‐Odasso, M., Amanullah, S., Black, S. E., Bocti, C., BORRIE, M. J., Feldman, H., et al. (2021) · Canadian Geriatrics Journal · doi:10.5770/cgj.24.570 · Cited by 12
Education to Improve Dementia Care:
Lee, L. S., Weston, W. W., & Hillier, L. M. (2018) · Family Medicine · doi:10.22454/fammed.2018.221401 · Cited by 12
Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer’s Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years
Kapoor, A., ONDRI Investigators, Bartha, R., Black, S. E., BORRIE, M. J., Freedman, M., Gao, F., Herrmann, N., Mandzia, J. L., Ozzoude, M., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191097 · Cited by 12
Empirically defining the preclinical stages of the Alzheimer's continuum in the Alzheimer's Disease Neuroimaging Initiative
Kiselica, A. M., & Initiative, A. D. N. (2021) · Psychogeriatrics · doi:10.1111/psyg.12697 · Cited by 13
Exploring acute care nurses' decision-making in psychotropic PRN use in hospitalised people with dementia
Walsh, B., Dahlke, S., O’Rourke, H., & Hunter, K. F. (2022) · Journal of Clinical Nursing · doi:10.1111/jocn.15477 · Cited by 11
Preference for emotionally meaningful activity in Alzheimer’s disease
Bohn, L., See, S. T. K., & Fung, H. H.-L. (2018) · Aging & Mental Health · doi:10.1080/13607863.2018.1506750 · Cited by 10
Olfactory groove and planum sphenoidale meningioma: Dementia masquerade.
Chiang, G. S. H., & Goh, L. G. (2017) · Europe PMC (PubMed Central) · Cited by 10
CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment
Brisson, M., Brodeur, C., Guillon, L. L., Masellis, M., Stoessl, A. J., Tamm, A., Zukotynski, K., Ismail, Z., Gauthier, S. G., Rosa‐Neto, P., et al. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12098 · Cited by 9
For How Long Should We Use Symptomatic Therapies to Treat People with Alzheimer Disease?
Rockwood, K. J. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405901201 · Cited by 10
Achieving the Goals of Dementia Plans: A Review of Evidence-Informed Implementation Strategies
Teper, M. H., Godard‐Sebillotte, C., & Vedel, I. (2019) · Healthcare policy · doi:10.12927/hcpol.2019.25860 · Cited by 9
Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer’s Dementia Are Frequently Below the Recommended Levels
Ortner, M., Stange, M., Schneider, H., Schroeder, C., Büerger, K., Müller, C., Dorn, B., Goldhardt, O., Diehl‐Schmid, J., Förstl, H., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00691 · Cited by 9
Informant‐based tools for assessment and monitoring of cognition, behavior, and function in neurocognitive disorders: Systematic review and report from a CCCDTD5 Working Group
Choudhury, S., Ghodasara, S., Stiffel, M., Fischer, C. E., Tang‐Wai, D. F., Smith, E. E., Massoud, F., Hsiung, G. R., Lee, L. S., Bruneau, M., et al. (2022) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5678 · Cited by 9
Prevalence of delusions in drug‐naïve Alzheimer disease patients: A meta‐analysis
Lai, L., Lee, P. E., Chan, P., Fok, M. C., Hsiung, G. R., & Sepehry, A. A. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4812 · Cited by 9
Development and validation of a priori risk model for extensive white matter lesions in people age 65 years or older: the Dijon MRI study
Tully, P. J., Qchiqach, S., Pereira, E., Debette, S., Mazoyer, B. M., & Tzourio, C. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-018328 · Cited by 8
CVLT-II short form forced choice recognition in a clinical dementia sample: Cautions for performance validity assessment
Grewal, K. S., Trites, M., Kirk, A., MacDonald, S. W. S., Morgan, D., Gowda-Sookochoff, R., & O’Connell, M. E. (2022) · Applied Neuropsychology Adult · doi:10.1080/23279095.2022.2079088 · Cited by 8
Les nouveaux critères de la Maladie d’Alzheimer – Perspective gériatrique*
Molin, P., & Rockwood, K. J. (2016) · Canadian Geriatrics Journal · doi:10.5770/cgj.19.242 · Cited by 13
Trends in the Use of Medications and Supplements to Treat or Prevent Dementia
Stoehr, G. P., Jacobsen, E. P., Jia, Y., Snitz, B. E., & Ganguli, M. (2019) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000357 · Cited by 7
Psychiatric Care of the Older Adult
DeMers, S. M., Dinsio, K., & Carlson, W. L. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.06.010 · Cited by 8
An overview of the rivastigmine 13.3 mg/24h transdermal patch as a treatment option for Alzheimer’s disease
Fortea, J., & Ferrer-Picón, E. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2527211 · Cited by 6
Treatment options for sundowning in patients with dementia
Blais, J. E., Zolezzi, M., & Sadowski, C. A. (2014) · Mental Health Clinician · doi:10.9740/mhc.n204525 · Cited by 7
The application of palliative care in dementia
Tajari, M., & Pandpazir, M. (2019) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_105_18 · Cited by 6
Treating Depression in Dementia Patients: A Risk or Remedy—A Narrative Review
Sultan, S. (2024) · Geriatrics · doi:10.3390/geriatrics9030064 · Cited by 6
Rural-Urban Differences in Healthcare Use in Persons With Dementia Between 2000 and 2019: A Quebec Population-Based Study
Arsenault‐Lapierre, G., Godard‐Sebillotte, C., Bui, T., Sourial, N., Rochette, L., Massamba, V. K., Sirois, C., Kosteniuk, J. G., Morgan, D., Quesnel‐Vallée, A., et al. (2024) · Healthcare policy · doi:10.12927/hcpol.2024.27281 · Cited by 5
Achieving the Goals of Dementia Plans: A Review of Evidence-Informed Implementation Strategies
Teper, M. H., Godard‐Sebillotte, C., & Vedel, I. (2019) · World health & population · doi:10.12927/whp.2019.26060 · Cited by 5
Evaluating the real-world representativeness of participants with mild cognitive impairment in Canadian research protocols: a comparison of the characteristics of a memory clinic patients and research samples
Huang, V., Hogan, D. B., Ismail, Z., Maxwell, C. J., Smith, E. E., & Callahan, B. L. (2020) · Canadian Geriatrics Journal · doi:10.5770/cgj.23.416 · Cited by 5
The association between the level of institutional support for dementia care in primary care practices and the quality of dementia primary care: A retrospective chart review
Henein, M., Arsenault‐Lapierre, G., Sourial, N., Godard‐Sebillotte, C., & Vedel, I. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12233 · Cited by 5
Description of organizational and clinician characteristics of primary dementia care in Canada: a multi-method study
Henein, M., Arsenault‐Lapierre, G., Sourial, N., Godard‐Sebillotte, C., Bergman, H., & Vedel, I. (2022) · BMC Family Practice · doi:10.1186/s12875-022-01732-9 · Cited by 5
Assessing care models implemented in primary healthcare for persons with dementia: a mixed-methods study protocol
Vedel, I., McAiney, C. A., Couturier, Y., Pakzad, S., Arsenault‐Lapierre, G., Godard‐Sebillotte, C., Sourial, N., Simmons, R., & Bergman, H. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035916 · Cited by 4
Health System Readiness for Disease-Modifying Therapies for Alzheimer Disease
CDA-AMC (2024) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2024.1038 · Cited by 5
Biological diagnosis of Alzheimer’s disease and the issue of stigma
Ronchetto, F., & Ronchetto, M. (2021) · Journal of Gerontology and Geriatrics · doi:10.36150/2499-6564-n327 · Cited by 4
Nurses’ decision‐making related to administering as needed psychotropic medication to persons with dementia: an empty systematic review
Walsh, B., Dahlke, S., O’Rourke, H. M., & Hunter, K. F. (2021) · International Journal of Older People Nursing · doi:10.1111/opn.12350 · Cited by 4
Diagnosis and Treatment of Dementia: the Fourth Canadian Consensus Conference
Patterson, C., & Gauthier, S. G. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt196 · Cited by 4
Detecting and Managing Neuropsychiatric Symptoms in Dementia
Iaboni, A., & Rapoport, M. J. (2017) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716672409 · Cited by 3
A palliative care perspective on deprescribing cholinesterase inhibitors in Alzheimer’s disease
Perri, G., & Liao, P. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1490255 · Cited by 3
Evaluation of a community-based memory clinic in collaboration with local hospitals to support patients with memory decline
Elbeddini, A., Tayefehchamani, Y., YILMAZ, Z. K., Villegas, J. J., & Zhang, E. Y. (2021) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2021.05.013 · Cited by 3
Base rates of low neuropsychological test scores in older adults with subjective cognitive impairment: Findings from a tertiary memory clinic
Grewal, K. S., Gowda-Sookochoff, R., Kirk, A., Morgan, D., & O’Connell, M. E. (2023) · Applied Neuropsychology Adult · doi:10.1080/23279095.2023.2208699 · Cited by 3
Déprescription des antipsychotiques pour les symptômes comportementaux et psychologiques de la démence et l’insomnie: Guide de pratique clinique fondé sur des données probantes
Bjerre, L. M., Farrell, B. J., Hogel, M., Graham, L. B., Lemay, G., McCarthy, L. M., Raman‐Wilms, L., Rojas‐Fernandez, C. H., Sinha, S. K., Thompson, W., et al. (2018) · Europe PMC (PubMed Central) · Cited by 3
Major or Mild Neurocognitive Disorder Due to Alzheimer Disease
Hategan, A., & Xiong, G. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-67555-8_18 · Cited by 3
Identification of Potential or Preclinical Cognitive Impairment and the Implications of Sophisticated Screening with Biomarkers and Cognitive Testing: Does It Really Matter?
Gordon, M. (2013) · BioMed Research International · doi:10.1155/2013/976130 · Cited by 3
Clinical practice guidelines on addressing cognitive impairment in vascular dementias
Singh, S. M., Kathiresan, P., & Gaur, N. (2025) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry.indianjpsychiatry_713_24 · Cited by 2
Pharmacological management of neuropsychiatric symptoms in patients with major neurocognitive disorders
Élie, D., & Rej, S. (2017) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.170117 · Cited by 2
Diagnostic Impact of Cerebrospinal Fluid Biomarkers in Atypical Dementias in Canada
van den Brink, S. E. M., Amrani, L. E., Therriault, J., Gauthier, S. G., Rosa‐Neto, P., & Vitali, P. (2020) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2020.196 · Cited by 2

Authors: Gauthier, S., Patterson, C., Chertkow, H., Gordon, M., Herrmann, N., Rockwood, K., Rosa-Neto, P., & Soucy, J.-P.
Affiliations: McGill University (CA)
McGill University Research Centre for Studies in Aging (CA)
Corresponding author: Gauthier, Serge
ORCID: Gauthier, Serge
Chertkow, Howard
Gordon, Michael
Herrmann, Nathan
Rockwood, Kenneth
Soucy, Jean-Paul
Venue: Canadian Geriatrics Journal
Publisher: Canadian Geriatrics Society
Published: 2012-09-20
Volume: 15
Issue: 4
Pages: 120-126
ISSN: 1925-8348 (ISSN-L)
DOI: 10.5770/cgj.15.49
PMC: PMC3516356
OpenAlex: W2153922623
Cited by: 137
References: 21
Citations by year: 2026: 1 · 2025: 3 · 2024: 6 · 2023: 3 · 2022: 11 · 2021: 12 · 2020: 17 · 2019: 14 · 2018: 11 · 2017: 15 · 2016: 12 · 2015: 10 · 2014: 11 · 2013: 11
FWCI: 7.31
Type: journal article
Language: en
Open access: diamond
doi.org
Licence: cc-by-nc-nd
Locations: Canadian Geriatrics Journal (publishedVersion, cc-by-nc-nd)
PubMed Central (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Funders: American Academy of Neurology
McGill University
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
Keywords: dementia, Alzheimer's disease, dementia diagnosis, dementia treatment, diagnostic criteria, NIA-AA criteria, clinical guidelines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks